HGF and cancer: Several studies suggest that MET, together with its ligand HGF, promotes cancer cell hallmarks including cell proliferation, survival, migration, angiogenesis in multiple mammalian cancer including hepatocellular carcinoma, head and neck cancer etc., (Goyal et al., 2013; Huang et al., 2020; Raj et al., 2022).